Recombinant Human Bone Morphogenetic Protein-2 Priming of Mesenchymal Stem Cells Ameliorate Acute Lung Injury by Inducing Regulatory T Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mesenchymal stromal/stem cells (MSCs) possess immunoregulatory properties and their regulatory functions represent a potential therapy for acute lung injury (ALI). However, uncertainties remain with respect to defining MSCs-derived immunomodulatory pathways. Therefore, this study aimed to investigate the mechanism underlying the enhanced effect of human recombinant bone morphogenic protein-2 (rhBMP-2) primed ES-MSCs (MSCBMP2) in promoting Tregs in ALI mice. MSC were preconditioned with 100 ng/ml rhBMP-2 for 24 h, and then administrated to mice by intravenous injection after intratracheal injection of 1 mg/kg LPS. Treating MSCs with rhBMP-2 significantly increased cellular proliferation and migration, and cytokines array reveled that cytokines release by MSCBMP2 were associated with migration and growth. MSCBMP2 ameliorated LPS induced lung injury and reduced myeloperoxidase activity and permeability in mice exposed to LPS. Levels of inducible nitric oxide synthase were decreased while levels of total glutathione and superoxide dismutase activity were further increased via inhibition of phosphorylated STAT1 in ALI mice treated with MSCBMP2. MSCBMP2 treatment increased the protein level of IDO1, indicating an increase in Treg cells, and Foxp3+CD25+ Treg of CD4+ cells were further increased in ALI mice treated with MSCBMP2. In co-culture assays with MSCs and RAW264.7 cells, the protein level of IDO1 was further induced in MSCBMP2. Additionally, cytokine release of IL-10 was enhanced while both IL-6 and TNF-α were further inhibited. In conclusion, these findings suggest that MSCBMP2 has therapeutic potential to reduce massive inflammation of respiratory diseases by promoting Treg cells.
Abstract
Mesenchymal stromal/stem cells (MSCs) possess immunoregulatory properties and their regulatory functions represent a potential therapy for acute lung injury (ALI). However, uncertainties remain with respect to defining MSCs-derived immunomodulatory pathways. Therefore, this study aimed to investigate the mechanism underlying the enhanced effect of human recombinant bone morphogenic protein-2 (rhBMP-2) primed ES-MSCs (MSCBMP2) in promoting Tregs in ALI mice. MSC were preconditioned with 100 ng/ml rhBMP-2 for 24 h, and then administrated to mice by intravenous injection after intratracheal injection of 1 mg/kg LPS. Treating MSCs with rhBMP-2 significantly increased cellular proliferation and migration, and cytokines array reveled that cytokines release by MSCBMP2 were associated with migration and growth. MSCBMP2 ameliorated LPS induced lung injury and reduced myeloperoxidase activity and permeability in mice exposed to LPS. Levels of inducible nitric oxide synthase were decreased while levels of total glutathione and superoxide dismutase activity were further increased via inhibition of phosphorylated STAT1 in ALI mice treated with MSCBMP2. MSCBMP2 treatment increased the protein level of IDO1, indicating an increase in Treg cells, and Foxp3+CD25+ Treg of CD4+ cells were further increased in ALI mice treated with MSCBMP2. In co-culture assays with MSCs and RAW264.7 cells, the protein level of IDO1 was further induced in MSCBMP2. Additionally, cytokine release of IL-10 was enhanced while both IL-6 and TNF-α were further inhibited. In conclusion, these findings suggest that MSCBMP2 has therapeutic potential to reduce massive inflammation of respiratory diseases by promoting Treg cells.
참고문헌 (63)
- Villarino AV, "Mechanisms of Jak", STAT signaling in immunity and disease, 2015, pp.194, 21~27
- Williams GW, "Acute respiratory distress syndrome", Anesthesiology, 134, pp.270~282 (2021)
- Ye Q, "The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19", J Infect, 80, pp.607~613 (2020)
- Sauer A, "Antibiotics as immunomodulators : a potential pharmacologic approach for ARDS treatment", Eur Respir Rev, 30, pp.210093~ (2021)
- Pierce LM, "Priming with toll-like receptor 3 agonist poly(I : C)enhances content of innate immune defense proteins but not microRNAs in human mesenchymal stem cell-derived extracellular vesicles", Front Cell Dev Biol, 9, pp.676356~ (2021)
- Wilson JG, "Mesenchymal stem(stromal)cells for treatment of ARDS : a phase 1 clinical trial", Lancet Respir Med, 3, pp.24~32 (2015)
- Matthay MA, "Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome(START study) : a randomised phase 2a safety trial", Lancet Respir Med, 7, pp.154~162 (2019)
- Fukumitsu M, "Mesenchymal stem", stromal cell therapy for pulmonary arterial hypertension : comprehensive review of preclinical studies, 2019, pp.74, 304~312
- Han J, "Strategies to enhance mesenchymal stem cell-based therapies for acute respiratory distress syndrome", Stem Cells Int, 2019, pp.5432134~ (2019)
- Li O, "Human embryonic stem cell-derived mesenchymal stroma cells(hES-MSCs)engraft in vivo and support hematopoiesis without suppressing immune function : implications for off-the shelf ES-MSC therapies", PLoS One, 8, pp.e55319~ (2013)
- Chen D, "Bone morphogenetic proteins", Growth Factors, 22, pp.233~241 (2004)
- Huang CC, "Functionally engineered extracellular vesicles improve bone regeneration", Acta Biomater, 109, pp.182~194 (2020)
- Cai H, "BMP2 induces hMSC osteogenesis and matrix remodeling", Mol Med Rep, 23, pp.125~ (2021)
- Yin X, "Intravenous transplantation of BMP2-transduced endothelial progenitor cells attenuates lipopolysaccharide-induced acute lung injury in rats", Cell Physiol Biochem, 35, pp.2149~2158 (2015)
- Wang K, "The effect of rhBMP-2 on pulmonary arterioles remodeling in endotoxin-induced acute lung injury in rats", Clin Exp Med, 13, pp.187~192 (2013)
- Cipolla EM, "Repair of the lung by regulatory T cells", Am J Respir Cell Mol Biol, 63, pp.405~407 (2020)
- Forteza MJ, "Activation of the regulatory t-cell", indoleamine 2, 3-dioxygenase axis reduces vascular inflammation and atherosclerosis in hyperlipidemic mice, 2018, pp.9, 950~
- Hwang SL, "Indoleamine 2, 3-dioxygenase(IDO)is essential for dendritic cell activation and chemotactic responsiveness to chemokines", Cell Res, 15, pp.167~175 (2005)
- Park JR, "The tri-peptide GHK-Cu complex ameliorates lipopolysaccharideinduced acute lung injury in mice", Oncotarget, 7, pp.58405~58417 (2016)
- Rahman I, "Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method", Nat Protoc, 1, pp.3159~3165 (2006)
- Park JR, "Isolation of human dermis derived mesenchymal stem cells using explants culture method : expansion and phenotypical characterization", Cell Tissue Bank, 16, pp.209~218 (2015)
- Baghaei K, "Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow", Gastroenterol Hepatol Bed Bench, 10, pp.208~213 (2017)
- Gabrielyan A, "IL-11 and soluble VCAM-1 are important components of hypoxia conditioned media and crucial for mesenchymal stromal cells attraction", Stem Cell Res, 45, pp.101814~ (2020)
- Zepp JA, "Distinct mesenchymal lineages and niches promote epithelial self-renewal and myofibrogenesis in the lung", Cell, 170, pp.1134~1148 (2017)
- Phipps MC, "Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds", PLoS One, 7, pp.e40831~ (2012)
- Chabot V, "Urokinase-type plasminogen activator receptor interaction with β1 integrin is required for platelet-derived growth factor-AB-induced human mesenchymal stem", stromal cell migration, 2015, pp.6, 188~
- Forte G, "Hepatocyte growth factor effects on mesenchymal stem cells : proliferation, migration, and differentiation", Stem Cells, 24, pp.23~33 (2006)
- He S, "Effect of brain-derived neurotrophic factor on mesenchymal stem cell-seeded electrospinning biomaterial for treating ischemic diabetic ulcers via milieu-dependent differentiation mechanism", Tissue Eng Part A, 21, pp.928~938 (2015)
- Li A, "PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRα and derepressing BMP-Smad1", 5, PLoS One, pp.2014, 9[DOI]
- Belotti D, "Thrombospondin-1 promotes mesenchymal stromal cell functions via TGFβ and in cooperation with PDGF", Matrix Biol, 55, pp.106~116 (2016)
- Kawata K, "Extracellular vesicles derived from mesenchymal stromal cells mediate endogenous cell growth and migration via the CXCL5and CXCL6", CXCR2 axes and repair menisci, 2021, pp.12, 414~
- Noronha NC, "Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies", Stem Cell Res Ther, 10, pp.131~ (2019)
- Lourenco S, "Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors", J Immunol, 194, pp.3463~3474 (2015)
- Cao G, "Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration", Am J Physiol Cell Physiol, 282, pp.C1181~ (2002)
- Krüger K, "Trefoil factor 3(TFF3)is involved in cell migration for skeletal repair", Int J Mol Sci, 20, pp.4277~ (2019)
- Sivanathan KN, "Interferon-gamma modification of mesenchymal stem cells : implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation", Stem Cell Rev Rep, 10, pp.351~375 (2014)
- Yang W, "Interleukin-11 regulates the fate of adipose-derived mesenchymal stem cells via STAT3 signalling pathways", Cell Prolif, 53, pp.e12771~ (2020)
- Zhang JM, "Platelet-derived growth factor-BB protects mesenchymal stem cells(MSCs)derived from immune thrombocytopenia patients against apoptosis and senescence and maintains MSC-mediated immunosuppression", Stem Cells Transl Med, 5, pp.1631~1643 (2016)
- Dorronsoro A, "Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation", Sci Rep, 10, pp.21853~ (2020)
- Xia W, "Improved survival of mesenchymal stem cells by macrophage migration inhibitory factor", Mol Cell Biochem, 404, pp.11~24 (2015)
- Liu XH, "Therapeutic potential of angiogenin modified mesenchymal stem cells : angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction", Microvasc Res, 76, pp.23~30 (2008)
- Tomonaga T, "Examination of surfactant protein D as a biomarker for evaluating pulmonary toxicity of nanomaterials in rat", Int J Mol Sci, 22, pp.4635~ (2021)
- Chow CW, "Oxidative stress and acute lung injury", Am J Respir Cell Mol Biol, 29, pp.427~431 (2003)
- Kellner M, "Ros signaling in the pathogenesis of acute lung injury(ALI)and acute respiratory distress syndrome(ARDS)", Adv Exp Med Biol, 967, pp.105~137 (2017)
- Lee H, "WKYMVm ameliorates acute lung injury via neutrophil antimicrobial peptide derived STAT1", IRF1 pathway, 2020, pp.533, 313~318
- Liang C, "Interferon-γ mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitro", Hematology, 23, pp.44~49 (2018)
- Liu Q, "Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression", Cell Death Dis, 12, pp.240~ (2021)
- Li X, "Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens", Stem Cell Res Ther, 10, pp.267~ (2019)
- Riezu-Boj JI, "Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection", J Hepatol, 54, pp.422~431 (2011)
- 김시나, "Galectin-9 is Involved in Immunosuppression Mediated by Human Bone Marrow-derived Clonal Mesenchymal Stem Cells", Immune Network, 15(5), pp.241~251 (2015), 대한면역학회[DOI]
- Wu J, "Immunity-and-matrixregulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis", Cell Res, 30, pp.794~809 (2020)
- Kim HN, "Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models", J Tissue Eng, 12 (2021)
- Ullah M, "Mesenchymal stromal cell homing : mechanisms and strategies for improvement", iScience, 15, pp.421~438 (2019)
- Legrand C, "Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling", J Cell Biol, 146, pp.517~529 (1999)
- Pricola KL, "Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1", 2-dependent mechanism, 2009, pp.108, 577~588
- Park KS, "Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles", Stem Cell Res Ther, 10, pp.288~ (2019)
- Zimmermann JA, "Enhanced immunosuppression of t cells by sustained presentation of bioactive interferon-gamma within three-dimensional mesenchymal stem cell constructs", Stem Cells Transl Med, 6, pp.223~237 (2017)
- Taylor MW, "Relationship between interferon-gamma, indoleamine 2, 3-dioxygenase, and tryptophan catabolism", FASEB J, 5, pp.2516~2522 (1991)
- Lepiller Q, "Antiviral and immunoregulatory effects of indoleamine-2, 3-dioxygenase in hepatitis C virus infection", J Innate Immun, 7, pp.530~544 (2015)
- Salminen A, "Role of indoleamine 2, 3-dioxygenase 1(IDO1)and kynurenine pathway in the regulation of the aging process", Ageing Res Rev, 75, pp.101573~ (2022)
- Norton DL, "Bronchoalveolar Tregs are associated with duration of mechanical ventilation in acute respiratory distress syndrome", J Transl Med, 18, pp.427~ (2020)
- Xue Y, "Indoleamine 2, 3-dioxygenase expression regulates the survival and proliferation of Fusobacterium nucleatum in THP-1-derived macrophages", Cell Death Dis, 9, pp.355~ (2018)
- Blumenthal A, "M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection", PLoS One, 7, pp.e37314~ (2012)
